US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist
  • 0.540
  • -0.038-6.56%
Close Jun 7 16:00 ET
  • 0.556
  • +0.015+2.85%
Post 18:22 ET
42.19MMarket Cap-514P/E (TTM)

Aligos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-63.79%986K
11.66%15.53M
-24.20%2.68M
-21.12%3.24M
86.46%6.89M
5.91%2.72M
219.04%13.91M
863.76%3.54M
167.14%4.11M
139.03%3.69M
Operating revenue
-63.79%986K
11.66%15.53M
-24.20%2.68M
-21.12%3.24M
86.46%6.89M
5.91%2.72M
219.04%13.91M
863.76%3.54M
167.14%4.11M
139.03%3.69M
Cost of revenue
Gross profit
Operating expense
-13.55%23.03M
-7.02%103.66M
9.38%28.68M
-3.23%22.31M
8.06%26.03M
-30.13%26.64M
-15.97%111.49M
-31.57%26.22M
-33.38%23.05M
-22.58%24.09M
Selling and administrative expenses
-21.63%6.67M
15.93%30.62M
-9.80%6.42M
22.42%6.44M
22.04%9.25M
31.84%8.51M
-7.42%26.41M
-26.74%7.12M
-18.69%5.26M
15.56%7.58M
-General and administrative expense
-21.63%6.67M
15.93%30.62M
-9.80%6.42M
22.42%6.44M
22.04%9.25M
31.84%8.51M
-7.42%26.41M
-26.74%7.12M
-18.69%5.26M
15.56%7.58M
Research and development costs
-9.75%16.37M
-14.15%73.04M
16.53%22.26M
-10.81%15.87M
1.64%16.78M
-42.75%18.14M
-18.32%85.08M
-33.21%19.1M
-36.76%17.79M
-32.76%16.51M
Operating profit
7.83%-22.05M
9.69%-88.13M
-14.62%-26M
-0.65%-19.07M
6.14%-19.14M
32.73%-23.92M
23.96%-97.58M
40.23%-22.68M
42.70%-18.95M
31.02%-20.39M
Net non-operating interest income expense
-22.46%580K
-24.21%1.24M
-267.24%-1.47M
115.67%1.01M
350.47%955K
769.77%748K
1,142.42%1.64M
1,447.69%876K
2,230.00%466K
194.44%212K
Non-operating interest income
-22.46%580K
-24.21%1.24M
-267.24%-1.47M
115.67%1.01M
350.47%955K
769.77%748K
1,142.42%1.64M
1,447.69%876K
2,230.00%466K
194.44%212K
Other net income (expense)
-5,364.96%-13.37M
129.67%54K
-50.00%152K
379.12%254K
-464.00%-182K
202.36%304K
Other non- operating income (expenses)
-5,364.96%-13.37M
----
----
129.67%54K
-50.00%152K
379.12%254K
----
----
-464.00%-182K
202.36%304K
Income before tax
-52.03%-34.84M
9.44%-86.88M
-27.87%-27.92M
3.49%-18.01M
9.27%-18.03M
35.56%-22.92M
25.16%-95.94M
42.19%-21.84M
43.44%-18.66M
33.28%-19.88M
Income tax
-38.46%24K
650.00%795K
-161.22%-30K
167.44%29K
1,510.64%757K
-26.42%39K
-25.87%106K
184.48%49K
-134.13%-43K
67.86%47K
Net income
-51.88%-34.86M
8.71%-87.68M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.96M
25.16%-96.05M
41.97%-21.89M
43.78%-18.62M
33.18%-19.92M
Net income continuous Operations
-51.88%-34.86M
8.71%-87.68M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.96M
25.16%-96.05M
41.97%-21.89M
43.78%-18.62M
33.18%-19.92M
Minority interest income
Net income attributable to the parent company
-51.88%-34.86M
8.71%-87.68M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.96M
25.16%-96.05M
41.97%-21.89M
43.78%-18.62M
33.18%-19.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-51.88%-34.86M
8.71%-87.68M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.96M
25.16%-96.05M
41.97%-21.89M
43.78%-18.62M
33.18%-19.92M
Basic earnings per share
58.49%-0.22
39.56%-1.36
27.17%-0.3714
6.82%-0.41
8.51%-0.43
36.90%-0.53
30.12%-2.25
42.70%-0.51
43.59%-0.44
40.51%-0.47
Diluted earnings per share
58.49%-0.22
39.56%-1.36
27.17%-0.3714
6.82%-0.41
8.51%-0.43
36.90%-0.53
30.12%-2.25
42.70%-0.51
43.59%-0.44
40.51%-0.47
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -63.79%986K11.66%15.53M-24.20%2.68M-21.12%3.24M86.46%6.89M5.91%2.72M219.04%13.91M863.76%3.54M167.14%4.11M139.03%3.69M
Operating revenue -63.79%986K11.66%15.53M-24.20%2.68M-21.12%3.24M86.46%6.89M5.91%2.72M219.04%13.91M863.76%3.54M167.14%4.11M139.03%3.69M
Cost of revenue
Gross profit
Operating expense -13.55%23.03M-7.02%103.66M9.38%28.68M-3.23%22.31M8.06%26.03M-30.13%26.64M-15.97%111.49M-31.57%26.22M-33.38%23.05M-22.58%24.09M
Selling and administrative expenses -21.63%6.67M15.93%30.62M-9.80%6.42M22.42%6.44M22.04%9.25M31.84%8.51M-7.42%26.41M-26.74%7.12M-18.69%5.26M15.56%7.58M
-General and administrative expense -21.63%6.67M15.93%30.62M-9.80%6.42M22.42%6.44M22.04%9.25M31.84%8.51M-7.42%26.41M-26.74%7.12M-18.69%5.26M15.56%7.58M
Research and development costs -9.75%16.37M-14.15%73.04M16.53%22.26M-10.81%15.87M1.64%16.78M-42.75%18.14M-18.32%85.08M-33.21%19.1M-36.76%17.79M-32.76%16.51M
Operating profit 7.83%-22.05M9.69%-88.13M-14.62%-26M-0.65%-19.07M6.14%-19.14M32.73%-23.92M23.96%-97.58M40.23%-22.68M42.70%-18.95M31.02%-20.39M
Net non-operating interest income expense -22.46%580K-24.21%1.24M-267.24%-1.47M115.67%1.01M350.47%955K769.77%748K1,142.42%1.64M1,447.69%876K2,230.00%466K194.44%212K
Non-operating interest income -22.46%580K-24.21%1.24M-267.24%-1.47M115.67%1.01M350.47%955K769.77%748K1,142.42%1.64M1,447.69%876K2,230.00%466K194.44%212K
Other net income (expense) -5,364.96%-13.37M129.67%54K-50.00%152K379.12%254K-464.00%-182K202.36%304K
Other non- operating income (expenses) -5,364.96%-13.37M--------129.67%54K-50.00%152K379.12%254K---------464.00%-182K202.36%304K
Income before tax -52.03%-34.84M9.44%-86.88M-27.87%-27.92M3.49%-18.01M9.27%-18.03M35.56%-22.92M25.16%-95.94M42.19%-21.84M43.44%-18.66M33.28%-19.88M
Income tax -38.46%24K650.00%795K-161.22%-30K167.44%29K1,510.64%757K-26.42%39K-25.87%106K184.48%49K-134.13%-43K67.86%47K
Net income -51.88%-34.86M8.71%-87.68M-27.44%-27.89M3.11%-18.04M5.69%-18.79M35.55%-22.96M25.16%-96.05M41.97%-21.89M43.78%-18.62M33.18%-19.92M
Net income continuous Operations -51.88%-34.86M8.71%-87.68M-27.44%-27.89M3.11%-18.04M5.69%-18.79M35.55%-22.96M25.16%-96.05M41.97%-21.89M43.78%-18.62M33.18%-19.92M
Minority interest income
Net income attributable to the parent company -51.88%-34.86M8.71%-87.68M-27.44%-27.89M3.11%-18.04M5.69%-18.79M35.55%-22.96M25.16%-96.05M41.97%-21.89M43.78%-18.62M33.18%-19.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -51.88%-34.86M8.71%-87.68M-27.44%-27.89M3.11%-18.04M5.69%-18.79M35.55%-22.96M25.16%-96.05M41.97%-21.89M43.78%-18.62M33.18%-19.92M
Basic earnings per share 58.49%-0.2239.56%-1.3627.17%-0.37146.82%-0.418.51%-0.4336.90%-0.5330.12%-2.2542.70%-0.5143.59%-0.4440.51%-0.47
Diluted earnings per share 58.49%-0.2239.56%-1.3627.17%-0.37146.82%-0.418.51%-0.4336.90%-0.5330.12%-2.2542.70%-0.5143.59%-0.4440.51%-0.47
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg